Biogen BIIB
NASDAQ BIIB
$220.83 -3.68 (-1.64%)
At close: Sep 4, 2026 · 4:00 PM EDT

Biogen (BIIB) EV to FCF (2009 - 2026)

Biogen (BIIB) posted EV to FCF of 75.09 for Q2 2026, up 95.88% on a QoQ basis from 38.34 in Q1 2026, and down 35.58% year-over-year from 116.56 in Q2 2025.

Analysis

Biogen (BIIB) EV to FCF (2009 - 2026) Analysis & Trends

Biogen has reported EV to FCF for 18 years, with the latest figure at 75.09 in Q2 2026.

  • On a quarterly basis, EV to FCF fell 35.58% year-over-year to 75.09 in Q2 2026; TTM through Jun 2026 was 11.36, a 43.61% increase from a year earlier, with the FY2025 full-year figure at 10.74, up 46.7% from the prior year.
  • EV to FCF was 75.09 for Q2 2026 at Biogen, up from 38.34 in the prior quarter.
  • The five-year high for EV to FCF was 260.53 in Q1 2022, with the low at 691.57 in Q4 2023.
  • Average EV to FCF over 5 years is 17.14, with a median of 54.75 recorded in 2024.
  • The largest YoY upside for EV to FCF was 345.45% in 2022 against a maximum downside of 433.84% in 2022.
  • Over 5 years, EV to FCF stood at 133.8 in 2022, then tumbled by 416.89% to 691.57 in 2023, then surged by 103.99% to 27.61 in 2024, then jumped by 70.43% to 47.05 in 2025, then jumped by 59.6% to 75.09 in 2026.
  • The last three EV to FCF figures came in at 75.09 (Q2 2026), 38.34 (Q1 2026), and 47.05 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.09
Mar 31, 2026 38.34
Dec 31, 2025 47.05
Sep 30, 2025 13.53
Jun 30, 2025 116.56
Mar 31, 2025 78.54
Dec 31, 2024 27.61
Sep 30, 2024 29.48
Jun 30, 2024 53.79
Mar 31, 2024 59.77
Dec 31, 2023 -691.57
Sep 30, 2023 67.44
Jun 30, 2023 84.54
Mar 31, 2023 90.54
Dec 31, 2022 -133.80
Sep 30, 2022 55.70
Jun 30, 2022 35.43
Mar 31, 2022 260.53
Dec 31, 2021 40.08
Sep 30, 2021 51.18